| Literature DB >> 29451596 |
Kadir González1, Rosendo Diaz2, Aurea F Ferreira3, Víctor García2, Héctor Paz1, José E Calzada1, Michelle Ruíz4, Márcia Laurenti3, Azael Saldaña1.
Abstract
Cutaneous leishmaniasis (CL) is an endemic disease in the Republic of Panama, caused by Leishmania (Viannia) parasites, whose most common clinical manifestation is the presence of ulcerated lesions on the skin. These lesions usually present a chronic inflammatory reaction, sometimes granulomatous, with the presence of lymphocytes, plasma cells and macrophages. This study describes the histopathological characteristics found in the skin lesions of patients with CL caused by Leishmania (V.) panamensis in Panama. We analyzed 49 skin biopsy samples from patients with clinical suspicion of CL, by molecular tests (PCR for subgenus Viannia and HSP-70) and by Hematoxylin-Eosin staining. Samples were characterized at the species level by PCR-HSP-70/RFLP. From the 49 samples studied, 46 (94%) were positive by PCR and were characterized as Leishmania (V.) panamensis. Of these, 48% were positive by Hematoxylin-Eosin staining with alterations being observed both, in the epidermis (85%) and in the dermis (100%) of skin biopsies. The inflammatory infiltrate was characterized according to histopathological patterns: lymphohistiocytic (50%), lymphoplasmacytic (61%) and granulomatous (46%) infiltration, being the combination of these patterns frequently found. The predominant histopathological characteristics observed in CL lesions caused by L. (V.) panamensis in Panama were: an intense inflammatory reaction in the dermis with a combination of lymphohistiocytic, lymphoplasmacytic and granulomatous presentation patterns and the presence of ulcers, acanthosis, exocytosis and spongiosis in the epidermis.Entities:
Mesh:
Year: 2018 PMID: 29451596 PMCID: PMC5813671 DOI: 10.1590/s1678-9946201860008
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Figure 1Amastigotes forms of Leishmania inside macrophages vacuoles in the dermis of patients affected by localized cutaneous leishmaniasis caused by L. (V.) panamensis (red arrows). (Hematoxilin-Eosin staining)
Figure 2Paraffin histological section of the skin lesion of a patient affected by localized cutaneous leishmaniasis caused by L. (V.) panamensis showing in A) acanthosis (black arrow), and in B) spongiosis (yellow arrow) and lymphohistiocytic exocytosis (blue arrow) (Hematoxilin-Eosin staining)
Histopathological findings observed in the epidermis of patients with cutaneous leishmaniasis caused by Leishmania (V.) panamensis in Panama
| EPIDERMIS | ||||||
|---|---|---|---|---|---|---|
|
| ||||||
| Ulcer | Acanthosis | Spongiosis | Exocytosis | Paraqueratosis | Hyperplasia | |
| Number | 20/46 | 19/46 | 18/46 | 16/46 | 8/46 | 3/46 |
| Percentage (%) | 43 | 41 | 39 | 35 | 17 | 7 |
Histopathological findings observed in the dermis of patients with cutaneous leishmaniasis caused by Leishmania (V.) panamensis in Panama
| DERMIS – INFLAMMATORY INFILTRATE | Amastigote | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| INTENSITY | DISTRIBUTION | CELLULAR TYPE | ||||||||
| Intense | Moderate | Discrete | Diffuse | Focal | *PMN | Lymphocyte | Plasma cell | Macrophage | ||
| Number | 18/46 | 26/46 | 2/46 | 17/46 | 29/46 | 38/46 (-) 8/46 (+) 0/46 (++) 0/46 (+++) | 0/46 (-) 2/46 (+) 15/46 (++) 29/46 (+++) | 2/46 (-) 14/46 (+) 20/46 (++) 10/46 (+++) | 1/46 (-) 19/46 (+) 15/46 (++) 11/46 (+++) | 24/46 (-) 15/46 (+) 2/46 (++) 5/46 (+++) |
| Percentage (%) | 39 | 57 | 4 | 37 | 63 | 83 (-) 17 (+) 0 (++) 0 (+++) | 0 (-) 4 (+) 33 (++) 63 (+++) | 4 (-) 30 (+) 44 (++) 22 (+++) | 2 (-) 41 (+) 33 (++) 24 (+++) | 52 (-) 33 (+) 4 (++) 11 (+++) |
*PMN: Polimorphonuclear
Figure 3Inflammatory patterns observed in cutaneous lesions caused by Leishmania (V.) panamensis. A) Intense and diffuse lymphohistiocytic inflammatory pattern; B) Intense lymphoplasmocytic inflammatory pattern; C) Granulomatous inflammatory pattern; D) Presence of multinucleated giant cells observed in the granulomatous reaction (Hematoxilin-Eosin staining)